Skip to main content
. 2014 Jun 11;23(2):195–201. doi: 10.1038/ejhg.2014.81

Figure 4.

Figure 4

Chromatin immunoprecipitation with anti-MeCP2 and control antibodies shows MeCP2 binding to the GRID1 promoter in SHSY-5Y neuroblastoma cells. The graph shows fold enrichment of target DNA isolated by ChIP using MeCP2 NH2 antibody normalized to a control preimmune antibody. Error bars show SEM. **P=0.0048 by two-tailed t-test, assuming unequal variance.